Plasma lipid lowering effects of doxazosin, a new selective alpha1 adrenergic inhibitor for systemic hypertension
- 29 May 1987
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 59 (14) , G46-G50
- https://doi.org/10.1016/0002-9149(87)90157-3
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Antihypertensive Treatment and Serum LipoproteinsJournal Of Hypertension, 1985
- The effect of antihypertensive drug treatment on mortality in the presence of resting electrocardiographic abnormalities at baseline: the HDFP experience. The Hypertension Detection and Follow-up Program Cooperative Research Group.Circulation, 1984
- Blood Lipid Effects of Antihypertensive Therapy: A Double‐Blind Comparison of the Effects of Methyldopa and PropranololThe Journal of Clinical Pharmacology, 1984
- Effect of trimazosin on serum lipid profiles in hypertensive patientsAmerican Heart Journal, 1983
- A Comparison of the Effects of Atenolol and Metoprolol on Serum LipoproteinsDrugs, 1983
- Long-Term Treatment with Slow Release Oxprenolol Alone, or in Combination with other Drugs: Effects on Blood Pressure, Lipoproteins and Exercise PerformanceAustralian and New Zealand Journal of Medicine, 1982
- Multiple risk functions for predicting coronary heart disease: The concept, accuracy, and applicationAmerican Heart Journal, 1982
- BETA-BLOCKERS OR DIURETICS IN HYPERTENSION? A SIX YEAR FOLLOW-UP OF BLOOD PRESSURE AND METABOLIC SIDE EFFECTSThe Lancet, 1981
- The effect of metoprolol on plasma lipidsPublished by Oxford University Press (OUP) ,1979
- Antihypertensive Effect and Side‐effects of Bendroflumethiazide and PropranololActa Medica Scandinavica, 1976